InvestorsHub Logo

DR5

02/10/19 11:19 AM

#2090 RE: superclown #2089

I agree with your agree. With the potential of $15 to 20 billion in sales of HemoStyp just in this country; I can see Beplate looking for $10 to $15 a share. Maybe even more, right Trust?